FDA recall D-0581-2018

Osmotica Pharmaceutical Corp · Class III · drug

Product

Methylphenidate Hydrochloride Extended-release Tablets, USP, 36 mg, 100-count bottle, Rx only, Trigen Laboratories, LLC Bridgewater, NJ 08807. NDC 13811-708-10

Reason for recall

Subpotent Drug:100-count product bottle labeled as Methylphenidate HCL ER Tablets 36 mg found to contain 1 27 mg Methylphenidate HCL ER Tablet.

Distribution

Nationwide in the USA

Key facts

Status
Terminated
Initiation date
2018-02-28
Report date
2018-03-14
Termination date
2019-05-01
Voluntary/Mandated
Voluntary: Firm initiated
Location
Marietta, GA, United States

Primary source

https://www.accessdata.fda.gov/scripts/ires/index.cfm?Product=D-0581-2018